CymaBay Therapeutics (CBAY) Misses Q1 EPS by 20c

CymaBay Therapeutics (NASDAQ: CBAY) reported Q1 EPS of ($0.29), $0.20 worse than the analyst estimate of ($0.09).

For earnings history and earnings-related data on CymaBay Therapeutics (CBAY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79